Nirsevimab

• Sign in to bookmark this resource.

  Sign in

---

Access Resources

• Job AidEN

About

This webpage features the drug dictionary entry for nirsevimab, providing the National Cancer Institute's definition. It describes nirsevimab as a special type of medicine called a monoclonal antibody. It is used to protect against respiratory syncytial virus (RSV) infections in babies and young children. The page also offers links to check for active clinical trials using this agent, as well as viewing it in the NCI Thesaurus.

---

Tags

Focus Area: Infectious Disease

Audiences: Families & Children; Nurses; Physicians; Public Health Professionals

Emergency Management Stage: Preparedness (Prevention / Protection)

Collection: Nirsevimab Library

Keywords: Immunoglobulin G; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Viral Fusion Proteins; Clinical Trial; Antibodies, Monoclonal, Humanized

Institutions: National Institutes of Health (NIH)

---

More like this

Wildfires and Children's Health Resources 2025 · National Institutes of Health (NIH) Measles Symptoms and Complications 2024 · Centers for Disease Control and Prevention (CDC) Nirsevimab-alip 50 mg/0.5 mL Intramuscular Syringe 2024 · First Databank, Kaiser Permanente

---

The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

---